← k3vl4r
Log inGet started →

PCVX (Vaxcyte Inc) Price Forecast

AI-generated price forecast for Vaxcyte Inc (PCVX) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads PCVX as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 60.43. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

60.43

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

PCVX forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+17.96%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called PCVX's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest PCVX news

From the market-news feed the forecasts are read against.

  • Vaxcyte: Vaccine Titan In The Making · SeekingAlpha · Oct 19
  • Wall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a Bet · Yahoo · Oct 14
  • Cantor Fitzgerald Reiterates Overweight on Vaxcyte, Announces $120 Price Target · Benzinga · Oct 12
  • BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push · Yahoo · Oct 9
  • Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Convertible Senior Notes · Yahoo · Oct 9

🔒

See the full PCVX forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

PCVX forecast — frequently asked

Will PCVX go up?

K3vl4r's calibrated AI forecast currently reads PCVX as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the PCVX price prediction for 2026?

K3vl4r's model projects PCVX toward $71.28 over the next ~4 weeks, a +18.0% move from $60.43. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

SHCCYHNBPHRTXMYOTWSTLGVNTARACOCPBGMSJBIOERNAKODMDXH

Will PCVX reach…?

Will PCVX reach $100.00?Will PCVX reach $200.00?Will PCVX reach $250.00?

Or see the full PCVX price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare PCVX

PCVX vs SHCPCVX vs CYHPCVX vs NBPPCVX vs HRTXPCVX vs MYOPCVX vs TWST

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.